Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

629 ARTÍCULOS , VIENDO DEL 256 AL 270

Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE) for the detection of dementia within a secondary care setting

Burton JK, Fearon P, Noel-Storr AH, McShane R, Stott DJ, Quinn TJ.

Cochrane Database Syst Rev. 2021 Jul 19;7(7):CD010772. doi: 10.1002/14651858.CD010772.pub3.

Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE) for the detection of dementia within community dwelling populations

Quinn TJ, Fearon P, Noel-Storr AH, Young C, McShane R, Stott DJ.

Cochrane Database Syst Rev. 2021 Jul 19;7(7):CD010079. doi: 10.1002/14651858.CD010079.pub3.

Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE) for the detection of dementia within a general practice (primary care) setting

Burton JK, Fearon P, Noel-Storr AH, McShane R, Stott DJ, Quinn TJ.

Cochrane Database Syst Rev. 2021 Jul 19;7(7):CD010771. doi: 10.1002/14651858.CD010771.pub3.

Home/community-based interventions to improve function in persons with mild cognitive impairment/early dementia

Jenkins E, Koirala B, Rodney T, Lee JW, Cotter VT, Szanton SL, Taylor JL.

Geriatr Nurs. 2021 Sep-Oct;42(5):1109-1124. doi: 10.1016/j.gerinurse.2021.06.023. Epub 2021 Jul 16.

Diagnostic test accuracy of telehealth assessment for dementia and mild cognitive impairment

McCleery J, Laverty J, Quinn TJ.

Cochrane Database Syst Rev. 2021 Jul 20;7(7):CD013786. doi: 10.1002/14651858.CD013786.pub2.

Prevalence of mild cognitive impairment in patients with hypertension: a systematic review and meta-analysis

Qin J, He Z, Wu L, Wang W, Lin Q, Lin Y, Zheng L.

Hypertens Res. 2021 Oct;44(10):1251-1260. doi: 10.1038/s41440-021-00704-3. Epub 2021 Jul 20.

Screening for cognitive impairment among individuals aged 60 years or over: scoping review

Feichtenberger PRP, Rocha MRL, Dos Santos Puga ME, Martinez JE.

Sao Paulo Med J. 2021 Aug-Sep;139(5):520-534. doi: 10.1590/1516-3180.2020.0635.150321.

Systematic Review of Different Neuroimaging Correlates in Mild Cognitive Impairment and Alzheimer's Disease

Talwar P, Kushwaha S, Chaturvedi M, Mahajan V.

Clin Neuroradiol. 2021 Dec;31(4):953-967. doi: 10.1007/s00062-021-01057-7. Epub 2021 Jul 23.

Editorial: Targets for Disease-Modifying Therapies in Alzheimer's Disease, Including Amyloid β and Tau Protein

Parums DV.

Med Sci Monit. 2021 Jul 26;27:e934077. doi: 10.12659/MSM.934077.

Fatty acids and beyond: Age and Alzheimer's disease related changes in lipids reveal the neuro-nutraceutical potential of lipids in cognition

Ooi KM, Vacy K, Boon WC.

Neurochem Int. 2021 Oct;149:105143. doi: 10.1016/j.neuint.2021.105143. Epub 2021 Jul 23.

Investigation of common risk factors between polycystic ovary syndrome and Alzheimer's disease: a narrative review

Sarahian N, Sarvazad H, Sajadi E, Rahnejat N, Eskandari Roozbahani N.

Reprod Health. 2021 Jul 26;18(1):156. doi: 10.1186/s12978-021-01203-x.

Mini-Mental State Examination (MMSE) for the early detection of dementia in people with mild cognitive impairment (MCI)

Arevalo-Rodriguez I, Smailagic N, Roqué-Figuls M, Ciapponi A, Sanchez-Perez E, Giannakou A, Pedraza OL, Bonfill Cosp X, Cullum S.

Cochrane Database Syst Rev. 2021 Jul 27;7(7):CD010783. doi: 10.1002/14651858.CD010783.pub3.

Decision-Making in People With Dementia or Mild Cognitive Impairment: A Narrative Review of Decision-Making Tools

Ho MH, Chang HR, Liu MF, Chien HW, Tang LY, Chan SY, Liu SH, John S, Traynor V.

J Am Med Dir Assoc. 2021 Oct;22(10):2056-2062.e4. doi: 10.1016/j.jamda.2021.06.034. Epub 2021 Jul 24.

Aducanumab: First Approval

Dhillon S.

Drugs. 2021 Aug;81(12):1437-1443. doi: 10.1007/s40265-021-01569-z.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias